Vantage Investment Advisors’s Celgene Corp CELG Stock Holding History

Vantage Investment Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$39K	Buy	440 +340	+340%	+$30K	0.01%	322
2018 Q2	$8K	Hold	100	–	–	﹤0.01%	586
2018 Q1	$9K	Hold	100	–	–	﹤0.01%	591
2017 Q4	$10K	Hold	100	–	–	﹤0.01%	593
2017 Q3	$15K	Hold	100	–	–	﹤0.01%	495
2017 Q2	$13K	Hold	100	–	–	﹤0.01%	511
2017 Q1	$12K	Sell	100 -10	-9%	-$1.2K	﹤0.01%	507
2016 Q4	$13K	Buy	110 +10	+10%	+$1.11K	0.01%	474
2016 Q3	$10K	Sell	100 -1,000	-91%	-$108K	﹤0.01%	508
2016 Q2	$108K	Hold	1,100	–	–	0.05%	166
2016 Q1	$110K	Sell	1,100 -190	-15%	-$19.6K	0.05%	154
2015 Q4	$154K	Sell	1,290 -100	-7%	-$11.6K	0.08%	127
2015 Q3	$150K	Buy	1,390 +1,290	+1,290%	+$160K	0.08%	128
2015 Q2	$12K	Buy	+100	New	+$11.4K	0.01%	455
2014 Q2	–	Sell	-200	Closed	-$14K	–	757
2014 Q1	$14K	Buy	+200	New	+$15.8K	0.01%	396

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vantage Investment Advisors's CELG Position: Q3 2018 in Review

Vantage Investment Advisors increased its Celgene Corp (CELG) stake by 340% in Q3 2018, buying an estimated $30K and bringing the position to 440 shares worth $39K. The position accounts for 0.01% of the portfolio, ranked #322.

Vantage Investment Advisors first reported a position in CELG in Q1 2014 and has held it in 15 quarters since. The position peaked at $154K in Q4 2015. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

Vantage Investment Advisors held 440 shares of Celgene Corp worth $39K as of Q3 2018.
Vantage Investment Advisors bought 340 Celgene Corp shares in Q3 2018, an estimated $30K.
Celgene Corp made up 0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #322 holding.
Vantage Investment Advisors first reported a position in Celgene Corp in Q1 2014 and has held it in 15 quarters since.
Vantage Investment Advisors's Celgene Corp position peaked at $154K in Q4 2015.
1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.